A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

CompletedOBSERVATIONAL

Enrollment

10,337

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions

Glaucoma, Open-AngleOcular Hypertension

Interventions

DRUG

bimatoprost 0.01%

Patients with POAG or OHT prescribed Lumigan® (bimatoprost 0.01%) treatment in a dose determined by the physician prior to study entry

Trial Locations (1)

Berlin